CLAFORAN Side Effects

6970177-2 | Anaemia, Haematoma
on Aug 27, 2010 Female patient from FRANCE , 63 years of age, was diagnosed with sepsis (What is sepsis?) and was treated with Claforan (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, haematoma. Claforan dosage: . During the same period patient was treated with FLAGYL (View Flagyl Review and Flagyl Label ), PREVISCAN (View Previscan Review and Previscan Label ), AMIKIN (View Amikin Review and Amikin Label ), FORTUM /UNK/ (View Fortum /unk/ Review and Fortum /unk/ Label ), AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ). Patient was hospitalized.

6802694-X | Abdominal Pain, Asthenia, Dehydration, Diarrhoea, Nausea, Pallor, Renal Failure Acute, Tachycardia
Patient was taking Claforan (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), asthenia, dehydration, diarrhoea, nausea (What is nausea?), pallor, renal failure acute, tachycardia on Jun 17, 2010 from FRANCE Additional patient health information: Female patient , 80 years of age, . Claforan dosage: . During the same period patient was treated with TAREG (View Tareg Review and Tareg Label ), ESOMEPRAZOLE (View Esomeprazole Review and Esomeprazole Label ), LEXOMIL (View Lexomil Review and Lexomil Label ), MEPRONIZINE (View Mepronizine Review and Mepronizine Label ), DOMPERIDONE (View Domperidone Review and Domperidone Label ), TARDYFERON /GFR/ (View Tardyferon /gfr/ Review and Tardyferon /gfr/ Label ). Patient was hospitalized.

6691476-8 | Acute Respiratory Distress Syndrome, Dermatitis Exfoliative, Skin Oedema
Adverse event was reported on Apr 16, 2010 by a Female patient taking Claforan (View Usage) (Dosage: ) . Location: FRANCE , 48 years of age, After Claforan was administered, patient had the following side effects: acute respiratory distress syndrome, dermatitis exfoliative, skin oedema. During the same period patient was treated with FLAMMAZINE (View Flammazine Review and Flammazine Label ), AMIKACIN (View Amikacin Review and Amikacin Label ). Patient was hospitalized.

6660476-6 | Pancytopenia
on Mar 29, 2010 Male patient from JAPAN , child 3 years of age, was diagnosed with brain abscess and was treated with Claforan (View Usage). Patient experienced the following unwanted or unexpected effects: pancytopenia. Claforan dosage: . During the same period patient was treated with VANCOMYCIN HYDROCHLORIDE (View Vancomycin Hydrochloride Review and Vancomycin Hydrochloride Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ).


6648167-9 | Abdominal Pain, Asthenia, Dehydration, Diarrhoea, Nausea, Pallor, Renal Failure Acute, Tachycardia
on Mar 19, 2010 Female patient from FRANCE , 80 years of age, was treated with Claforan (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), asthenia, dehydration, diarrhoea, nausea (What is nausea?), pallor, renal failure acute, tachycardia. Claforan dosage: . During the same period patient was treated with TAREG (View Tareg Review and Tareg Label ), ESOMEPRAZOLE (View Esomeprazole Review and Esomeprazole Label ), LEXOMIL (View Lexomil Review and Lexomil Label ), MEPRONIZINE (View Mepronizine Review and Mepronizine Label ), DOMPERIDONE (View Domperidone Review and Domperidone Label ), TARDYFERON /GFR/ (View Tardyferon /gfr/ Review and Tardyferon /gfr/ Label ). Patient was hospitalized.

6603158-9 | International Normalised Ratio Increased, Overdose, Rectal Haemorrhage
Patient was taking Claforan (View Usage). After Claforan was administered, patient had the following side effects: international normalised ratio increased, overdose, rectal haemorrhage on Feb 22, 2010 from FRANCE Additional patient health information: Female patient , 84 years of age, was diagnosed with meningitis (What is meningitis?) and. Claforan dosage: . During the same period patient was treated with PREVISCAN (1/2 Df During 2 Days Every 3 Days) (View Previscan Review and Previscan Label ), AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ). Patient was hospitalized.

6566377-6 | Pyrexia, Renal Failure Acute
Adverse event was reported on Jan 29, 2010 by a Male patient taking Claforan (View Usage) (Dosage: ) was diagnosed with sepsis (What is sepsis?) and. Location: FRANCE , 78 years of age, Patient experienced the following unwanted or unexpected effects: pyrexia, renal failure acute. During the same period patient was treated with GENTAMICIN (View Gentamicin Review and Gentamicin Label ), COVERSYL /FRA/ (View Coversyl /fra/ Review and Coversyl /fra/ Label ). Patient was hospitalized.

6551484-4 | Cytolytic Hepatitis
on Jan 20, 2010 Female patient from FRANCE , 23 years of age, was diagnosed with infection (What is infection?), influenza, pain (What is pain?), bacterial infection (What is bacterial infection?), asthma (What is asthma?), cough, vomiting, gastrooesophageal reflux disease and was treated with Claforan (View Usage). Patient had the following side effects: cytolytic hepatitis. Claforan dosage: . During the same period patient was treated with OSELTAMIVIR (View Oseltamivir Review and Oseltamivir Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), PULMICORT (View Pulmicort Review and Pulmicort Label ), EXOMUC (View Exomuc Review and Exomuc Label ), DOMPERIDONE (View Domperidone Review and Domperidone Label ), VENTOLIN (View Ventolin Review and Ventolin Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

6419595-1 | Agranulocytosis, Overdose
on Oct 22, 2009 Male patient from , 70 years of age, was diagnosed with thrombosis prophylaxis, hypothyroidism and was treated with Claforan (View Usage). After Claforan was administered, patient had the following side effects: agranulocytosis, overdose. Claforan dosage: . During the same period patient was treated with CLAMOXYL /00249601/ (View Clamoxyl /00249601/ Review and Clamoxyl /00249601/ Label ), AMIKLIN /00391001/ (View Amiklin /00391001/ Review and Amiklin /00391001/ Label ), HEPARIN (View Heparin Review and Heparin Label ), HEMISUCCINATE OF HYDROCORTISONE (View Hemisuccinate Of Hydrocortisone Review and Hemisuccinate Of Hydrocortisone Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), DOSTINEX (View Dostinex Review and Dostinex Label ), NEXIUM (View Nexium Review and Nexium Label ), MORPHINE (View Morphine Review and Morphine Label ). Patient was hospitalized.

6419594-X | Agitation, Anaphylactic Reaction, Blood Pressure Decreased, Larynx Irritation, Pulmonary Haemorrhage
Patient was taking Claforan (View Usage). Patient experienced the following unwanted or unexpected effects: agitation, anaphylactic reaction, blood pressure decreased, larynx irritation, pulmonary haemorrhage on Oct 20, 2009 from CHINA Additional patient health information: Male patient , child 10 years of age, was diagnosed with tracheitis and. Claforan dosage: . During the same period patient was treated with AMBROXOL HYDROCHLORIDE (View Ambroxol Hydrochloride Review and Ambroxol Hydrochloride Label ), AZITHROMYCIN (Dose: Unk) (View Azithromycin Review and Azithromycin Label ). Patient was hospitalized.

6416128-0 | Asphyxia, Hypersensitivity, Laryngeal Oedema
Adverse event was reported on Oct 20, 2009 by a Male patient taking Claforan (View Usage) (Dosage: ) . Location: CHINA , child 2 years of age, Patient had the following side effects: asphyxia, hypersensitivity, laryngeal oedema.

6393901-9 | Heparin-induced Thrombocytopenia, Venous Thrombosis
on Sep 28, 2009 Male patient from , 76 years of age, was treated with Claforan (View Usage). After Claforan was administered, patient had the following side effects: heparin-induced thrombocytopenia, venous thrombosis. Claforan dosage: . During the same period patient was treated with TIAPRIDAL /00435701/ (View Tiapridal /00435701/ Review and Tiapridal /00435701/ Label ), HEPARINE CALCIQUE (View Heparine Calcique Review and Heparine Calcique Label ), ZYVOXID (View Zyvoxid Review and Zyvoxid Label ), DOBUTAMINE HCL (View Dobutamine Hcl Review and Dobutamine Hcl Label ). Patient was hospitalized.

6345484-7 | Eosinophilia, Hepatitis Fulminant, Pyrexia
on Sep 03, 2009 Male patient from JAPAN , weighting 18.74 lb, was diagnosed with bronchitis (What is bronchitis?), pain (What is pain?) and was treated with Claforan (View Usage). Patient experienced the following unwanted or unexpected effects: eosinophilia, hepatitis fulminant, pyrexia. Claforan dosage: . During the same period patient was treated with MEROPEN (View Meropen Review and Meropen Label ), MUCODYNE (View Mucodyne Review and Mucodyne Label ), MUCOSOLVAN (View Mucosolvan Review and Mucosolvan Label ), OPIUM ALKALOIDS AND DERIVATIVES (View Opium Alkaloids And Derivatives Review and Opium Alkaloids And Derivatives Label ), BENZODIAZEPINE DERIVATIVES (View Benzodiazepine Derivatives Review and Benzodiazepine Derivatives Label ), ESCRE (View Escre Review and Escre Label ), CEFDINIR (View Cefdinir Review and Cefdinir Label ), ASVERIN /00465502/ (View Asverin /00465502/ Review and Asverin /00465502/ Label ).

6275194-6 | Eosinophilia, Hepatitis Fulminant, Pyrexia
Patient was taking Claforan (View Usage). Patient had the following side effects: eosinophilia, hepatitis fulminant, pyrexia on Jul 14, 2009 from JAPAN Additional patient health information: Male patient , weighting 18.74 lb, was diagnosed with bronchitis (What is bronchitis?), pain (What is pain?) and. Claforan dosage: . During the same period patient was treated with ROCEPHIN (View Rocephin Review and Rocephin Label ), MEROPEN (View Meropen Review and Meropen Label ), MUCODYNE (View Mucodyne Review and Mucodyne Label ), MUCOSOLVAN (View Mucosolvan Review and Mucosolvan Label ), OPIUM ALKALOIDS AND DERIVATIVES (View Opium Alkaloids And Derivatives Review and Opium Alkaloids And Derivatives Label ), BENZODIAZEPINE DERIVATIVES (View Benzodiazepine Derivatives Review and Benzodiazepine Derivatives Label ), ESCRE (View Escre Review and Escre Label ), CEFDINIR (View Cefdinir Review and Cefdinir Label ).

6243661-7 | Renal Failure Acute
Adverse event was reported on Jun 18, 2009 by a Female patient taking Claforan (View Usage) (Dosage: ) . Location: , 13 years of age, After Claforan was administered, patient had the following side effects: renal failure acute. During the same period patient was treated with VANCOMYCINE (View Vancomycine Review and Vancomycine Label ), GENTAMICINE (View Gentamicine Review and Gentamicine Label ), CLAMOXYL /00249601/ (View Clamoxyl /00249601/ Review and Clamoxyl /00249601/ Label ), ZOVIRAX (View Zovirax Review and Zovirax Label ). Patient was hospitalized.

6243658-7 | Agranulocytosis, Lymphopenia, Pyrexia, Thrombocytopenia
on Jun 15, 2009 Male patient from , child 7 years of age, was diagnosed with meningitis (What is meningitis?) and was treated with Claforan (View Usage). Patient experienced the following unwanted or unexpected effects: agranulocytosis, lymphopenia, pyrexia, thrombocytopenia. Claforan dosage: . During the same period patient was treated with FOSFOCINE (View Fosfocine Review and Fosfocine Label ), CIPROFLOXACIN HCL (View Ciprofloxacin Hcl Review and Ciprofloxacin Hcl Label ). Patient was hospitalized.

6229317-5 | Mycotic Aneurysm
on Jun 08, 2009 Male patient from , 50 years of age, was diagnosed with meningoencephalitis bacterial and was treated with Claforan (View Usage). Patient had the following side effects: mycotic aneurysm. Claforan dosage: . During the same period patient was treated with VANCOMYCINE (View Vancomycine Review and Vancomycine Label ), ZYVOXID (View Zyvoxid Review and Zyvoxid Label ), CIPROFLOXACIN HCL (View Ciprofloxacin Hcl Review and Ciprofloxacin Hcl Label ). Patient was hospitalized.

6222929-4 | Disorientation, Hallucination
Patient was taking Claforan (View Usage). After Claforan was administered, patient had the following side effects: disorientation, hallucination on Jun 02, 2009 from FRANCE Additional patient health information: Female patient , 67 years of age, . Claforan dosage: . Patient was hospitalized.

6211497-9 | Hepatic Function Abnormal, Pancytopenia
Adverse event was reported on May 28, 2009 by a Male patient taking Claforan (View Usage) (Dosage: ) was diagnosed with meningitis (What is meningitis?), encephalitis herpes, pneumonia (What is pneumonia?) and. Location: JAPAN , 60 years of age, weighting 93.70 lb, Patient experienced the following unwanted or unexpected effects: hepatic function abnormal, pancytopenia. During the same period patient was treated with VICCILLIN (View Viccillin Review and Viccillin Label ), VICCLOX (View Vicclox Review and Vicclox Label ), PISULCIN (View Pisulcin Review and Pisulcin Label ), WARFARIN (View Warfarin Review and Warfarin Label ), SOLULACT (View Solulact Review and Solulact Label ), SOLUTIONS AFFECTING THE ELECTROLYTE BALANCE (View Solutions Affecting The Electrolyte Balance Review and Solutions Affecting The Electrolyte Balance Label ), FLUNITRAZEPAM (View Flunitrazepam Review and Flunitrazepam Label ). Patient was hospitalized.

6203383-5 | Agranulocytosis, Lymphopenia, Pyrexia, Thrombocytopenia
on May 19, 2009 Male patient from , child 7 years of age, was diagnosed with meningitis (What is meningitis?) and was treated with Claforan (View Usage). Patient had the following side effects: agranulocytosis, lymphopenia, pyrexia, thrombocytopenia. Claforan dosage: . During the same period patient was treated with FOSFOCINE (View Fosfocine Review and Fosfocine Label ), CIPROFLOXACIN HCL (View Ciprofloxacin Hcl Review and Ciprofloxacin Hcl Label ). Patient was hospitalized.

6161579-5 | Hepatic Function Abnormal, Pancytopenia
on Apr 15, 2009 Male patient from JAPAN , 60 years of age, weighting 93.70 lb, was diagnosed with meningitis (What is meningitis?), encephalitis herpes, pneumonia (What is pneumonia?) and was treated with Claforan (View Usage). After Claforan was administered, patient had the following side effects: hepatic function abnormal, pancytopenia. Claforan dosage: . During the same period patient was treated with VICCILLIN (View Viccillin Review and Viccillin Label ), VICCLOX (View Vicclox Review and Vicclox Label ), PISULCIN (View Pisulcin Review and Pisulcin Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), SOLULACT (View Solulact Review and Solulact Label ), SOLUTIONS AFFECTING THE ELECTROLYTE BALANCE (View Solutions Affecting The Electrolyte Balance Review and Solutions Affecting The Electrolyte Balance Label ), FLUNITRAZEPAM (View Flunitrazepam Review and Flunitrazepam Label ). Patient was hospitalized.

6160096-6 | Agranulocytosis, Dermatitis Exfoliative
Patient was taking Claforan (View Usage). Patient experienced the following unwanted or unexpected effects: agranulocytosis, dermatitis exfoliative on Apr 09, 2009 from Additional patient health information: Male patient , 39 years of age, was diagnosed with meningitis (What is meningitis?) and. Claforan dosage: . During the same period patient was treated with FOSFOMYCINE (View Fosfomycine Review and Fosfomycine Label ). Patient was hospitalized.

6143380-1 | Toxic Epidermal Necrolysis
Adverse event was reported on Mar 30, 2009 by a Male patient taking Claforan (View Usage) (Dosage: Dose: 1 G / Bottle) . Location: JAPAN , 82 years of age, Patient had the following side effects: toxic epidermal necrolysis. During the same period patient was treated with ALEVIATIN (View Aleviatin Review and Aleviatin Label ).

6127891-0 | Eosinophilia, Mononucleosis Syndrome, Pyrexia
on Mar 18, 2009 Female patient from , 44 years of age, was diagnosed with meningitis (What is meningitis?), pain (What is pain?) and was treated with Claforan (View Usage). After Claforan was administered, patient had the following side effects: eosinophilia, mononucleosis syndrome, pyrexia. Claforan dosage: . During the same period patient was treated with AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), SKENAN (View Skenan Review and Skenan Label ), MYOLASTAN (View Myolastan Review and Myolastan Label ), RIFAMPICIN (View Rifampicin Review and Rifampicin Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), CORTANCYL (View Cortancyl Review and Cortancyl Label ). Patient was hospitalized.

6121316-7 | Atrial Fibrillation, Clostridium Difficile Colitis, Diarrhoea, Hypokalaemia
on Mar 12, 2009 Female patient from , 84 years of age, was treated with Claforan (View Usage). Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?), clostridium difficile colitis, diarrhoea, hypokalaemia. Claforan dosage: . During the same period patient was treated with CIFLOX /00697201/ (View Ciflox /00697201/ Review and Ciflox /00697201/ Label ), TRIFLUCAN (View Triflucan Review and Triflucan Label ), GENTALLINE (View Gentalline Review and Gentalline Label ), APROVEL (View Aprovel Review and Aprovel Label ), VASTAREL (View Vastarel Review and Vastarel Label ), IMOVANE (View Imovane Review and Imovane Label ), PROPOFAN /00765201/ (View Propofan /00765201/ Review and Propofan /00765201/ Label ).

6057132-4 | Erythema, Pain, Pruritus, Skin Exfoliation
Patient was taking Claforan (View Usage). Patient had the following side effects: erythema, pain (What is pain?), pruritus, skin exfoliation on Jan 15, 2009 from Additional patient health information: Male patient , 81 years of age, . Claforan dosage: . During the same period patient was treated with CLAMOXYL /00249601/ (View Clamoxyl /00249601/ Review and Clamoxyl /00249601/ Label ), HEMIGOXINE (View Hemigoxine Review and Hemigoxine Label ), ATARAX (View Atarax Review and Atarax Label ), NEXIUM (View Nexium Review and Nexium Label ), LASIX (View Lasix Review and Lasix Label ), DIFFU K (View Diffu K Review and Diffu K Label ), RIFAMYCINE (View Rifamycine Review and Rifamycine Label ). Patient was hospitalized.

6055713-5 | Blood Creatinine Increased, Renal Failure Acute
Adverse event was reported on Apr 24, 2008 by a Male patient taking Claforan (View Usage) (Dosage: ) was diagnosed with prophylaxis and. Location: , 80 years of age, After Claforan was administered, patient had the following side effects: blood creatinine increased, renal failure acute. During the same period patient was treated with VANCOMYCINE (View Vancomycine Review and Vancomycine Label ), GENTAMICINE (View Gentamicine Review and Gentamicine Label ), LASIX (View Lasix Review and Lasix Label ), PLAVIX (View Plavix Review and Plavix Label ), TEMERIT (View Temerit Review and Temerit Label ), KENZEN (View Kenzen Review and Kenzen Label ), ZOCOR (View Zocor Review and Zocor Label ). Patient was hospitalized.

6051870-5 | Atrial Fibrillation, Clostridium Difficile Colitis, Diarrhoea, Hypokalaemia
on Jan 15, 2009 Female patient from , 84 years of age, was treated with Claforan (View Usage). Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?), clostridium difficile colitis, diarrhoea, hypokalaemia. Claforan dosage: . During the same period patient was treated with CIFLOX /00697201/ (View Ciflox /00697201/ Review and Ciflox /00697201/ Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), GENTALLINE (View Gentalline Review and Gentalline Label ).

6022747-6 | Pancytopenia
on Dec 25, 2008 Female patient from JAPAN , child 1 years of age, was treated with Claforan (View Usage). Patient had the following side effects: pancytopenia. Claforan dosage: . During the same period patient was treated with MEROPENEM (View Meropenem Review and Meropenem Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ).

6010867-1 | Dermatitis Exfoliative, Eosinophilia
Patient was taking Claforan (View Usage). After Claforan was administered, patient had the following side effects: dermatitis exfoliative, eosinophilia on Dec 12, 2008 from Additional patient health information: Male patient , 61 years of age, was diagnosed with sepsis (What is sepsis?), abscess (What is abscess?) and. Claforan dosage: . During the same period patient was treated with DALACINE (View Dalacine Review and Dalacine Label ), TAVANIC (View Tavanic Review and Tavanic Label ). Patient was hospitalized.

5925730-1 | Cytolytic Hepatitis
Adverse event was reported on Oct 16, 2008 by a Female patient taking Claforan (View Usage) (Dosage: ) was diagnosed with meningitis (What is meningitis?) and. Location: , 27 years of age, Patient experienced the following unwanted or unexpected effects: cytolytic hepatitis. During the same period patient was treated with RIVOTRIL (View Rivotril Review and Rivotril Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), FOSFOCINE (View Fosfocine Review and Fosfocine Label ). Patient was hospitalized.

5913981-1 | Condition Aggravated, Eosinophilia
on Sep 30, 2008 Male patient from FRANCE , 83 years of age, was diagnosed with erythema multiforme and was treated with Claforan (View Usage). Patient had the following side effects: condition aggravated, eosinophilia. Claforan dosage: . During the same period patient was treated with LOVENOX (View Lovenox Review and Lovenox Label ), KARDEGIC /00002703/ (View Kardegic /00002703/ Review and Kardegic /00002703/ Label ), LIPANOR (View Lipanor Review and Lipanor Label ), XATRAL /00975301/ (View Xatral /00975301/ Review and Xatral /00975301/ Label ), ERYTHROMYCIN (View Erythromycin Review and Erythromycin Label ), LASIX (View Lasix Review and Lasix Label ), JOSACIN /00273601/ (View Josacin /00273601/ Review and Josacin /00273601/ Label ).

5911055-7 | Cytolytic Hepatitis
on Sep 30, 2008 Female patient from , 27 years of age, was diagnosed with meningitis (What is meningitis?) and was treated with Claforan (View Usage). After Claforan was administered, patient had the following side effects: cytolytic hepatitis. Claforan dosage: . During the same period patient was treated with VANCOMYCIN HCL (View Vancomycin Hcl Review and Vancomycin Hcl Label ), RIVOTRIL (View Rivotril Review and Rivotril Label ), FOSFOCINE (View Fosfocine Review and Fosfocine Label ). Patient was hospitalized.

5895442-1 | Toxic Epidermal Necrolysis
Patient was taking Claforan (View Usage). Patient experienced the following unwanted or unexpected effects: toxic epidermal necrolysis on Sep 19, 2008 from JAPAN Additional patient health information: Male patient , 82 years of age, . Claforan dosage: Dose: 1 G / Bottle.

5888332-1 | Abdominal Pain, Eosinophilia, Eyelid Oedema, Hypersensitivity, Hypotension, Malaise, Oedema Mouth, Rash Morbilliform, Tachycardia
Adverse event was reported on Sep 11, 2008 by a Female patient taking Claforan (View Usage) (Dosage: ) . Location: , child 8 years of age, weighting 48.50 lb, Patient had the following side effects: abdominal pain (What is abdominal pain?), eosinophilia, eyelid oedema, hypersensitivity, hypotension, malaise, oedema mouth, rash morbilliform, tachycardia. During the same period patient was treated with TARGOCID (View Targocid Review and Targocid Label ), VANCOMYCIN HCL (View Vancomycin Hcl Review and Vancomycin Hcl Label ). Patient was hospitalized.

5851318-7 | Anaemia, Thrombocytopenia
on Aug 13, 2008 Male patient from , 68 years of age, was diagnosed with sepsis (What is sepsis?) and was treated with Claforan (View Usage). After Claforan was administered, patient had the following side effects: anaemia, thrombocytopenia. Claforan dosage: . During the same period patient was treated with DUPHALAC (View Duphalac Review and Duphalac Label ), VITAMIN B1 1MGM TAB (View Vitamin B1 1mgm Tab Review and Vitamin B1 1mgm Tab Label ), VITAMIN B6 (View Vitamin B6 Review and Vitamin B6 Label ), ACTRAPID (View Actrapid Review and Actrapid Label ), ALBUMIN (HUMAN) (View Albumin (human) Review and Albumin (human) Label ), KAYEXALATE (View Kayexalate Review and Kayexalate Label ), TRANXENE (View Tranxene Review and Tranxene Label ), NICOBION (View Nicobion Review and Nicobion Label ). Patient was hospitalized.

5822534-5 | Cardiac Arrest
on Jul 16, 2008 Male patient from PAKISTAN , weighting 6.17 lb, was diagnosed with sepsis (What is sepsis?) and was treated with Claforan (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?). Claforan dosage: Dose: 125mg Bd. Patient was hospitalized.

5789444-3 | Agranulocytosis, Anaemia, Petechiae
Patient was taking Claforan (View Usage). Patient had the following side effects: agranulocytosis, anaemia, petechiae on Dec 11, 2007 from Additional patient health information: Male patient , 74 years of age, was diagnosed with septic shock, meningitis (What is meningitis?) and. Claforan dosage: . During the same period patient was treated with RIFADIN (View Rifadin Review and Rifadin Label ), VANCOMYCIN HCL (View Vancomycin Hcl Review and Vancomycin Hcl Label ), AUGMENTIN '125' (View Augmentin '125' Review and Augmentin '125' Label ). Patient was hospitalized.

5752119-0 | Skin Exfoliation, Urticaria
Adverse event was reported on May 22, 2008 by a Female patient taking Claforan (View Usage) (Dosage: ) . Location: , 55 years of age, After Claforan was administered, patient had the following side effects: skin exfoliation, urticaria. During the same period patient was treated with CIFLOX /00697201/ (View Ciflox /00697201/ Review and Ciflox /00697201/ Label ). Patient was hospitalized.

5749406-9 | Renal Cancer, Thrombocytopenia
on May 20, 2008 Male patient from , 73 years of age, was treated with Claforan (View Usage). Patient experienced the following unwanted or unexpected effects: renal cancer, thrombocytopenia. Claforan dosage: . During the same period patient was treated with CALCIPARINE (View Calciparine Review and Calciparine Label ), FOSFOCINE (View Fosfocine Review and Fosfocine Label ), ACUPAN (View Acupan Review and Acupan Label ), AVLOCARDYL (View Avlocardyl Review and Avlocardyl Label ), LEXOMIL (View Lexomil Review and Lexomil Label ). Patient was hospitalized.

5724978-9 | Blood Creatinine Increased, Renal Failure Acute
on Apr 24, 2008 Male patient from , 80 years of age, was diagnosed with prophylaxis, cardiac disorder and was treated with Claforan (View Usage). Patient had the following side effects: blood creatinine increased, renal failure acute. Claforan dosage: . During the same period patient was treated with VANCOMYCIN HCL (View Vancomycin Hcl Review and Vancomycin Hcl Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ), LASILIX /00032601/ (View Lasilix /00032601/ Review and Lasilix /00032601/ Label ), PLAVIX (View Plavix Review and Plavix Label ), TEMERIT (View Temerit Review and Temerit Label ), KENZEN (View Kenzen Review and Kenzen Label ), ZOCOR (View Zocor Review and Zocor Label ). Patient was hospitalized.

5719520-2 | Chest Discomfort, Cough, Dyspnoea, Infusion Related Reaction
Patient was taking Claforan (View Usage). After Claforan was administered, patient had the following side effects: chest discomfort, cough, dyspnoea, infusion related reaction on Apr 25, 2008 from UNITED STATES Additional patient health information: Female patient , 68 years of age, weighting 209.0 lb, . Claforan dosage: .

5711164-1 | Meningitis
Adverse event was reported on Apr 14, 2008 by a Male patient taking Claforan (View Usage) (Dosage: ) was diagnosed with meningitis (What is meningitis?) and. Location: JAPAN , weighting 27.78 lb, Patient experienced the following unwanted or unexpected effects: meningitis (What is meningitis?). During the same period patient was treated with TARGOCID (Dose Quantity: 68) (View Targocid Review and Targocid Label ), VICCILLIN (Dose Quantity: 200) (View Viccillin Review and Viccillin Label ), CARBENIN (Dose Quantity: 130) (View Carbenin Review and Carbenin Label ), VANCOMYCIN (Dose Quantity: 60) (View Vancomycin Review and Vancomycin Label ), IMMUNE GLOBULIN INTRAVENOUS (HUMAN) (View Immune Globulin Intravenous (human) Review and Immune Globulin Intravenous (human) Label ).

5674995-2 | Meningitis
on Mar 14, 2008 Male patient from JAPAN , weighting 27.78 lb, was diagnosed with meningitis (What is meningitis?) and was treated with Claforan (View Usage). Patient had the following side effects: meningitis (What is meningitis?). Claforan dosage: . During the same period patient was treated with TARGOCID (Dose Quantity: 68) (View Targocid Review and Targocid Label ), VICCILLIN (Dose Quantity: 200) (View Viccillin Review and Viccillin Label ), CARBENIN (Dose Quantity: 130) (View Carbenin Review and Carbenin Label ), VANCOMYCIN (Dose Quantity: 60) (View Vancomycin Review and Vancomycin Label ), IMMUNE GLOBULIN INTRAVENOUS (HUMAN) (View Immune Globulin Intravenous (human) Review and Immune Globulin Intravenous (human) Label ).

5636957-0 | Renal Failure Acute
on Feb 19, 2008 Male patient from , 80 years of age, was treated with Claforan (View Usage). After Claforan was administered, patient had the following side effects: renal failure acute. Claforan dosage: . During the same period patient was treated with GENTAMICIN (View Gentamicin Review and Gentamicin Label ). Patient was hospitalized.

5633128-9 | Dermatitis Exfoliative, Oedema Peripheral, Pruritus
Patient was taking Claforan (View Usage). Patient experienced the following unwanted or unexpected effects: dermatitis exfoliative, oedema peripheral, pruritus on Feb 12, 2008 from Additional patient health information: Female patient , 67 years of age, was diagnosed with prophylaxis and. Claforan dosage: . During the same period patient was treated with AUGMENTIN '125' (View Augmentin '125' Review and Augmentin '125' Label ), BRICANYL (View Bricanyl Review and Bricanyl Label ), ATROVENT (View Atrovent Review and Atrovent Label ), LOVENOX (View Lovenox Review and Lovenox Label ). Patient was hospitalized.

5627730-8 | Pancreatitis Acute
Adverse event was reported on Feb 11, 2008 by a Female patient taking Claforan (View Usage) (Dosage: ) was diagnosed with pain (What is pain?), prophylaxis and. Location: , 79 years of age, Patient had the following side effects: pancreatitis acute. During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), VANCOMYCIN HCL (View Vancomycin Hcl Review and Vancomycin Hcl Label ), HYPNOVEL /00634103/ (View Hypnovel /00634103/ Review and Hypnovel /00634103/ Label ), FENTANYL RENAUDIN (View Fentanyl Renaudin Review and Fentanyl Renaudin Label ), PERFALGAN (View Perfalgan Review and Perfalgan Label ), CLAMOXYL /00249601/ (View Clamoxyl /00249601/ Review and Clamoxyl /00249601/ Label ), MOPRAL (View Mopral Review and Mopral Label ).

5599946-0 | Renal Failure Acute
on Jan 11, 2008 Male patient from , 71 years of age, was diagnosed with endocarditis (What is endocarditis?) and was treated with Claforan (View Usage). After Claforan was administered, patient had the following side effects: renal failure acute. Claforan dosage: . During the same period patient was treated with OFLOCET /00731801/ (View Oflocet /00731801/ Review and Oflocet /00731801/ Label ), GENTALLINE (View Gentalline Review and Gentalline Label ). Patient was hospitalized.

5594684-2 | Panniculitis
on Jan 09, 2008 Male patient from , 73 years of age, was treated with Claforan (View Usage). Patient experienced the following unwanted or unexpected effects: panniculitis. Claforan dosage: . During the same period patient was treated with TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ), VESANOID (Dose: 50-40) (View Vesanoid Review and Vesanoid Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), DEXAMETHASONE TAB (View Dexamethasone Tab Review and Dexamethasone Tab Label ), LEXOMIL (View Lexomil Review and Lexomil Label ), RIVOTRIL (View Rivotril Review and Rivotril Label ). Patient was hospitalized.

5582808-2 | Abdominal Pain, Eosinophilia, Eyelid Oedema, Hypersensitivity, Hypotension, Malaise, Oedema Mouth, Rash Morbilliform, Tachycardia
Patient was taking Claforan (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), eosinophilia, eyelid oedema, hypersensitivity, hypotension, malaise, oedema mouth, rash morbilliform, tachycardia on Dec 28, 2007 from Additional patient health information: Female patient , child 8 years of age, weighting 48.50 lb, . Claforan dosage: . During the same period patient was treated with TARGOCID (View Targocid Review and Targocid Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ). Patient was hospitalized.